A trusted name in life sciences investing

For 25 years, Genesys Capital has been one of Canada’s leading early-stage venture firms dedicated to life sciences. With funds across multiple vintages and a growing LP base of institutional investors, family offices, and high-net-worth individuals, the firm has built its reputation on technical excellence and transparent stewardship.

But reporting life sciences investments — especially across complex scientific and financial dimensions — creates unique challenges:

• Not all LPs have a background in biotech

• Many require tailored communication

• And as fund complexity grew, so did the cost of manual reporting

The challenge of reporting in life sciences VC

But as the firm scaled to four active funds, reporting became increasingly complex:

• LPs had different preferences (tax, deal, IR contacts)

• Email-based workflows led to missed updates and duplication

• The biotech sector required added explanation for non-technical LPs

“We were sending reports manually, in batches, to different people across each LP’s organization — and still getting emails saying they didn’t receive what they needed.”

This wasn’t just an operational problem. It was a threat to the LP experience Genesys had worked hard to build.

The turning point

As the fourth fund launched, Jennifer knew something had to change. The volume of reporting, the rise in special LP requests, and the need for clarity — especially in a technically complex sector — made legacy methods unsustainable.

Through a trusted advisor and peer firm reference, Genesys discovered Vessel.

“The timing was perfect. We needed a solution — not just for efficiency, but for LP engagement. Vessel gave us both.”

What Vessel unlocked for Genesys

Vessel transformed the firm’s investor relations in four key ways:

• Reporting became scalable: Instead of manually sorting contacts and reports, Jennifer’s team now uploads once and tags by LP role (IR, tax, legal).

• Engagement became self-serve: LPs log into a clean portal to see key fund metrics and download relevant documents — on their time, not the GP’s.

• Communication became tailored: Whether the LP is a biotech expert or a generalist allocator, the right level of information reaches the right person.

• Time was given back: The team now spends less time formatting and chasing down document requests — and more time preparing strategic updates.

“Our LPs are busy people. They don’t always want to email us to find something. With Vessel, they don’t have to.”

Why Genesys would recommend Vessel to other GPs

“The onboarding was lightning fast. We were up and running without disrupting our existing reporting cycle.”

— Jennifer Williams

Here’s why Genesys would recommend Vessel to other emerging or established GPs:

• Blazing-fast onboarding, even in the middle of a fund cycle

• Vessel’s AI file organizer eliminates manual folder sorting and tagging

• LPs love the experience — calling it “slick,” “easy,” and “intuitive”

• Dedicated WhatsApp channel made the Vessel team reachable 24/7 for anything we needed

• The Vessel team feels like an extension of ours — responsive, thoughtful, and product-forward.

Whether you’re managing three funds or scaling to seven, Vessel adapts to your stack — and upgrades the LP experience from day one.

“Vessel unlocked a very easy way for us to present our fund metrics to LPs. It’s not just about automation — it’s about clarity and confidence.”

“Our LPs are busy people. They don’t always want to email us to find something. With Vessel, they don’t have to.”